IITRI offers a wide range of bioanalytical services for the detection and quantification of both small molecule and biologic drug candidates from human clinical trial samples. Two recent publications highlight our experience in determining drug and hormone concentrations from human clinical trial samples of plasma, breast tissue, and nipple aspirate fluid (NAF).


Methodological considerations in estrogen assays of breast fluid and tissue

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast

Related News

Breast-cancer drug has a surprising new application, study finds